Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Abroad (travel likely)Recruiting

Conditions

Carcinoma, Hepatocellular

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mays Cancer Center, San Antonio, Texas, United States
Contact: Study coordinator (Gina Alvarez, RN) · alvarezg1@uthscsa.edu · 210-450-5893

Study leads

Sukeshi Patel Arora, MD
Principal Investigator
Mays Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Carcinoma, Hepatocellular · Neoplasms, Glandular and Epithelial · Adenocarcinoma

Abroad (travel likely)Recruiting

Shanghai, China